SMS Pharmaceuticals Ltd successfully completes USFDA inspection at Central Laboratory Analytical Services

SMS Pharmaceuticals Limited has announced the second successful completion of the United States Food and Drug Administration (USFDA) inspection at our Central Laboratory Analytical Services, located at, Gagillapur Village, Medchal Malkajgiri District, Hyderabad, Telangana.

The inspection, conducted from 23rd June 2025 to 25th June 2025, concluded with zero Form 483 observations.

The Company is committed to meeting the highest quality standards and is further committed to full compliance with CGMP & GLP regulations at all our manufacturing & Analytical facilities. The "Central Laboratory Analytical Services" is our independent testing laboratory, and this was the second successful USFDA inspection for the facility.

Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 239.05 as compared to the previous close of Rs. 233.65. The total number of shares traded during the day was 11975 in over 246 trades.

The stock hit an intraday high of Rs. 239.50 and intraday low of 235.45. The net turnover during the day was Rs. 2847265.00.

Source : Equity Bulls

Keywords

SMSPharmaceuticals INE812G01025 USFDA Inspection SuccessfulCompletion CentralLaboratoryAnalyticalServices